Chemomab Therapeutics（CMMB.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

公众及其他71.38%
机构投资者12.29%
个人与内部人士11.12%
私营企业5.21%

主要股东

主要股东最新
股东
Erik Otto	5.36%	38.61 万	0.02%	+1,125.00	2026/08/10
Erik Otto	5.33%	38.61 万	0.02%	+1,125.00	2026/08/10
Touchstone Global Investments Pty Ltd	5.21%	37.78 万	--	+37.78 万	2026/08/07
Presight Capital Management Company, L.L.C.	3.93%	28.30 万	<0.01%	+0	2025/05/23
Presight Capital Management Company, L.L.C.	3.91%	28.30 万	0.02%	+0	2025/05/23
Peter Thiel	3.85%	27.71 万	<0.01%	+0	2025/12/31
Peter Thiel	3.82%	27.71 万	0.02%	+0	2025/12/31
HBM Partners Ltd.	3.16%	22.75 万	--	+22.75 万	2026/07/09
HBM Partners Ltd.	3.14%	22.75 万	--	+22.75 万	2026/07/09
Citadel Advisors LLC	1.32%	9.53 万	0.42%	+3.11 万	2026/06/30
Adi GeorgeCo-Founder, Chief Scientific Officer, CEO & Executive Director	1.23%	8.88 万	0.68%	-4.85 万	2026/03/18
Adi GeorgeCo-Founder, Chief Scientific Officer, CEO & Executive Director	1.23%	8.88 万	<0.01%	+0	2026/03/18
ADAR1 Capital Management, LLC	1.11%	8.00 万	<0.01%	+0	2026/03/31
ADAR1 Capital Management, LLC	1.10%	8.00 万	<0.01%	+0	2026/06/30
Citadel Advisors LLC	0.89%	6.42 万	0.55%	-3.96 万	2026/03/31
Kestra Private Wealth Services, LLC	0.86%	6.17 万	0.00%	+0	2026/06/30
Kestra Private Wealth Services, LLC	0.85%	6.17 万	<0.01%	+0	2026/06/30
Ikarian Capital, LLC	0.72%	5.18 万	<0.01%	+0	2026/03/31
Ikarian Capital, LLC	0.71%	5.18 万	<0.01%	+0	2026/06/30
Neil CohenIndependent Director	0.49%	3.53 万	<0.01%	-1.00	2026/03/18